engleski

Commentary on article by Rudavsky and Freeman - Treatment of scan-negative, thyroglobulin-positive metastatic thyroid cancer using radioiodine 131-I and recombinant human thyroid stimulating hormone

We read with great interest the case report by Rudavsky and Freeman (1) presenting the use of recombinant human TSH (rh TSH) to stimulate uptake of 131I in the treatment of metastatic differentiated thyroid cancer (DTC). With this exciting approach one could avoid the necessity to withdraw thyroid supression therapy and associated hypothyroid morbidity. However, we found a few missing points and inconsistencies in the clinical course of that report...

radioiodine scan; thyroglobulin; thyroid carcinoma; metastases

nije evidentirano